Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 25/2/2021
SIETES contiene 93212 citas

 
 
 1 a 20 de 285 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Lee SWH, Lai NM, Chaiyakunapruk N, Chong DWK. Adverse effects of herbal or dietary supplements in G6PD deficiency: a systematic review. Br J Clin Pharmacol 2017;83:172-9. [Ref.ID 101929]
2.Enlace a cita originalTiene citas relacionadas Cita con resumen
Cummings SR, Kiel DP, Black DM. Vitamin D supplementation and increased risk of falling. A cautionary tale of vitamin supplements retold. JAMA Intern Med 2016;176:febrero. [Ref.ID 100024]
3. Cita con resumen
4.Enlace a cita original Cita con resumen
Kristal AR, Darke AK, Morris S, Tangen CM, Goodman PJ, Thompson IM, Meyskens jr FL, Goodman GE, Minasian LM, Parnes HL, Lippman SM, Klein EA. Baseline selenium status and effects of selenium and vitamin E supplementation on prostate cancer risk. J Natl Cancer Inst 2014;106:456. [Ref.ID 97156]
5.Tiene citas relacionadas Cita con resumen
Dysken MW, Sano M, Asthana S, Vertrees JE, Pallaki M, LLorente M, Love S, Schellenberg GD, McCarten R, Malphurs J, Prieto S, Chen P, Loreck DJ, Trapp G, Bakshi RS, Mintzer JE, Heidebrink JL, Vidal-Cardona A, Arroyo LM, Cruz AR, Zachariah S, Kowall NW, Chopra MP, Craft S, Thielke S, Turvey CL, Woodman C, Monnells KA, Gordon K, Tomaska J, Segal Y, Peduzzi PN, Guarino PD. ·Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA 2014;311:33-44. [Ref.ID 97033]
6.Tiene citas relacionadas
Evans DA, Morris MC, Rajan KB. Vitamin E, memantine, and Alzheimer disease. JAMA 2014;311:29-30. [Ref.ID 97032]
7. Cita con resumen
Briggs JP, Killen J. Perspectives on complementary and alternative medicine research. JAMA 2013;310:691-2. [Ref.ID 95950]
8.Enlace a cita original Cita con resumen
Elyasi S, Khalili H, Hatamkhani S, Dashti-Khavidaki S. Prevention of vancomycin induced nephrotoxicity: a review of preclinical data. Eur J Clin Pharmacol 2013;69:747-54. [Ref.ID 95190]
9.Enlace a cita original
Tsai HH, Lin HW, Pickard SA, Tsai HY, Mahady GB. Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review. International Journal of Clinical Practice 2012;66:1056-78. [Ref.ID 93669]
10. Cita con resumen
Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL, King SB, Kigfield PD, Krumholz HM, Kwong RYK, Lim MJ, Linderbaum JA, Mack MJ, Munger MA, Sabik JF, Shaw LJ, Sikkema JD, Smith Jr CR, Smith Jr SC, Spertus JA, Williams SV. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2012;60:e44-e164. [Ref.ID 93287]
11. Cita con resumen
Khan KS, Champaneria R, Latthe PM. How effective are non-drug- non-surgical treatments for primary dysmenorrhoea?. BMJ 2012;344:43-5. [Ref.ID 93009]
12.Enlace a cita original
Chopra K, Tiwari V. Alcoholic neuropathy: possible mechanisms and future treatment possibilities. Br J Clin Pharmacol 2012;73:348-62. [Ref.ID 92461]
13. Cita con resumen
Anónimo. Who should take vitamin supplements?. Med Lett Drugs Ther 2011;53:101-3. [Ref.ID 91904]
14. Cita con resumen
Klein EA, Thompson Jr IM, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parners HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens Jr FL, Baker LH. Vitamin E and the risk of prostate cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011;306:1549-56. [Ref.ID 91543]
15. Cita con resumen
Bordeaux JS, Martires KJ, Goldberg D, Pattee SF, Fu P, Maloney ME. Prospective evaluation of dermatologic surgery complications including patients on multiple antiplatelet and anticoagulant medications. J Am Acad Dermatol 2011;65:576-83. [Ref.ID 91005]
16. Cita con resumen
De Caterina R. N-3 fatty acids and cardiovascular disease. N Engl J Med 2011;364:2439-50. [Ref.ID 90939]
17. Cita con resumen
Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, Abrams SH, Scheimann AO, Sanyal AJ, Chalasani N, Tonascia J, Ünalp A, Clark JM, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR, for the Nonalcoholic Steatohepatitis Clinical Research Network. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents. The TONIC randomized controlled trial. JAMA 2011;305:1659-68. [Ref.ID 90533]
18.
Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet 2011;377:1019-31. [Ref.ID 90421]
19. Cita con resumen
Schürks M, Glynn RJ, Rist PM, Tzourio C, Kurth T. Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ 2010;341:1033. [Ref.ID 89654]
20.Tiene citas relacionadas
Sanyal AJ, Ünalp A, for the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Investigators. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. The authors reply. N Engl J Med 2010;363:1186. [Ref.ID 89365]
Seleccionar todas
 
 1 a 20 de 285 siguiente >>